Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Nosocomial spread of OXA-58-positive carbapenem-resistant Acinetobacter baumannii isolates in a paediatric hospital in Greece.

Poirel L, Lebessi E, Héritier C, Patsoura A, Foustoukou M, Nordmann P.

Clin Microbiol Infect. 2006 Nov;12(11):1138-41.

2.
3.

Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii.

Héritier C, Poirel L, Nordmann P.

Clin Microbiol Infect. 2006 Feb;12(2):123-30.

4.

Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii.

Héritier C, Poirel L, Fournier PE, Claverie JM, Raoult D, Nordmann P.

Antimicrob Agents Chemother. 2005 Oct;49(10):4174-9.

5.

Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe.

Marqué S, Poirel L, Héritier C, Brisse S, Blasco MD, Filip R, Coman G, Naas T, Nordmann P.

J Clin Microbiol. 2005 Sep;43(9):4885-8.

6.

Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii.

Héritier C, Poirel L, Lambert T, Nordmann P.

Antimicrob Agents Chemother. 2005 Aug;49(8):3198-202.

7.
8.

OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Poirel L, Marqué S, Héritier C, Segonds C, Chabanon G, Nordmann P.

Antimicrob Agents Chemother. 2005 Jan;49(1):202-8.

9.

A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.

Héritier C, Dubouix A, Poirel L, Marty N, Nordmann P.

J Antimicrob Chemother. 2005 Jan;55(1):115-8. Epub 2004 Dec 8.

PMID:
15590718
10.

In vivo acquisition of high-level resistance to imipenem in Escherichia coli.

Poirel L, Héritier C, Spicq C, Nordmann P.

J Clin Microbiol. 2004 Aug;42(8):3831-3.

11.
12.
13.

Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae.

Poirel L, Héritier C, Tolün V, Nordmann P.

Antimicrob Agents Chemother. 2004 Jan;48(1):15-22.

14.

First description of CTX-M-15-producing Klebsiella pneumoniae in Turkey.

Lartigue MF, Poirel L, Heritier C, Tolun V, Nordmann P.

J Antimicrob Chemother. 2003 Aug;52(2):315-6. Epub 2003 Jul 15. No abstract available.

PMID:
12865392
15.

Emergence in Klebsiella pneumoniae of a chromosome-encoded SHV beta-lactamase that compromises the efficacy of imipenem.

Poirel L, Héritier C, Podglajen I, Sougakoff W, Gutmann L, Nordmann P.

Antimicrob Agents Chemother. 2003 Feb;47(2):755-8.

16.

Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii.

Héritier C, Poirel L, Aubert D, Nordmann P.

Antimicrob Agents Chemother. 2003 Jan;47(1):268-73.

17.

The acute effects of amisulpride (50 mg and 200 mg) and haloperidol (2 mg) on cognitive function in healthy elderly volunteers.

Legangneux E, McEwen J, Wesnes KA, Bergougnan L, Miget N, Canal M, L'Heritier C, Pinquier JL, Rosenzweig P.

J Psychopharmacol. 2000 Jun;14(2):164-71.

PMID:
10890311
18.

Acute effects of zolpidem, triazolam and flunitrazepam on arterial blood gases and control of breathing in severe COPD.

Murciano D, Armengaud MH, Cramer PH, Neveux E, L'Héritier C, Pariente R, Aubier M.

Eur Respir J. 1993 May;6(5):625-9.

PMID:
8519370
19.

Pilot studies on the effect of SL 82.0715 in psychotic syndromes.

Garreau M, Giroux C, L'Heritier C, Coupez M, Eich F, Morselli PL.

Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:699A-700A. No abstract available.

PMID:
1354073
20.

Long-term treatment of insomnia with zolpidem: a multicentre general practitioner study of 107 patients.

Schlich D, L'Heritier C, Coquelin JP, Attali P, Kryrein HJ.

J Int Med Res. 1991 May-Jun;19(3):271-9. Erratum in: J Int Med Res 1993 Nov-Dec;21(6):346.

PMID:
1670039
21.

Double-blind, placebo-controlled, cross-over trial of progabide as add-on therapy in epileptic patients.

de Pasquet EG, Scaramelli A, de Cáceres MP, L'Héritier C, Feldman S, Santana R, Aguilar J, Musch B, Morselli PL.

Epilepsia. 1991 Jan-Feb;32(1):133-9.

PMID:
1985823
22.

[Double-blind versus placebo comparison of single dose alpidem (50 mg or 75 mg) in a model of situational anxiety].

Regnier F, Chastel A, L'Heritier C, Magni G, Henry M.

Therapie. 1989 Jul-Aug;44(4):279-83. French.

PMID:
2574502
23.

Grass pollen hyposensitization versus placebo therapy.

Weyer A, Heritier CL, David B.

Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M. 1983;(78):101-7. No abstract available.

PMID:
6354089
24.

Grass pollen hyposensitization versus placebo therapy. II. Immunotherapy-induced changes in serum IgE and IgG levels.

Weyer A, Doinel C, Debbia M, L'Heritier C, Rivat L, Le Mao J, Hirth C, David B.

Allergy. 1981 Jul;36(5):319-28. No abstract available.

PMID:
7032342
25.
26.

Differentiated cancers of the thyroid: course after treatment with special reference to frequency and chronology of the first relapse for 470 treated patients.

Gardet P, Parmentier C, Gerard-Marchant R, L'Heritier C, Caillou B, Cukersztein W, Tubiana M.

Ann Radiol (Paris). 1977 Nov-Dec;20(8):831-40. No abstract available.

PMID:
610558
27.

Radioiodine treatment in differentiated thyroid carcinomas. Treatment of first local recurrences and of bone and lung metastases.

Charbord P, L'Heritier C, Cukersztein W, Lumbroso J, Tubiana M.

Ann Radiol (Paris). 1977 Nov-Dec;20(8):783-6. No abstract available.

PMID:
610550

Supplemental Content

Loading ...
Support Center